Results 131 to 140 of about 35,596 (239)

Main contribution of UGT1A1 and CYP2C9 in the metabolism of UR-1102, a novel agent for the treatment of gout

, 2020
Mizuki Yamane, Fumihiko Igarashi, Tsuyoshi Yamauchi, Toshito Nakagawa   +3 more
openalex   +2 more sources

Letter to the Editor in Response to “Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally” [PDF]

, 2019
Aaron Lazorwitz, Christina L. Aquilante, Jeanelle Sheeder, Stephanie Teal   +3 more
openalex   +1 more source

The Relationship Between Warfarin Resistance and CYP2C9*2 and CYP2C9*3 Variatıons

Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2021
Deniz Kıraç, Aysun Erdem Yaman, Tansu Doran, Elif Çiğdem Altunok   +3 more
openaire   +1 more source

Licochalcone A as Novel Multitarget Inhibitors via AChE, BuChE, and Synapsin III for Therapeutic Intervention Against Alzheimer’s Disease: Computer‐Aided Drug Design

Journal of Chemistry, Volume 2026, Issue 1, 2026.
Alzheimer’s disease (AD) is characterized by key pathological features, including cholinergic dysfunction, amyloid‐beta (Aβ) aggregation, and disrupted synaptic transmission, positioning proteins such as acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), and Synapsin III as critical targets for therapeutic strategies.
Ali Alimari, Bagher Seyedalipour, Payam Baziyar, Ehsan Joz Jalalian, Sohini Basu Roy   +4 more
wiley   +1 more source

Antihemolytic and Thrombolytic Potential of Ocimum basilicum Seed Extract, Bioactive Compounds, and Docking With VanA Ligase in Vancomycin‐Resistant Staphylococci

Journal of Tropical Medicine, Volume 2026, Issue 1, 2026.
Ocimum basilicum is an important alternative source to explore diverse anti‐infective compounds. In the present study, aqueous seed extract of O. basilicum was used to identify bioactive compounds with antihemolytic, thrombolytic, antivancomycin‐resistant Staphylococcus aureus and antivancomycin‐resistant S. epidermidis activity.
Khalaf F. Alsharif, Hazir Rahman, Zhengwei Huang   +2 more
wiley   +1 more source

Rapid detection of the known SNPs of CYP2C9 using oligonucleotide microarray

, 2003
Siyuan Wen
openalex   +2 more sources

Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug‐induced idiosyncratic liver injury (DILI) [PDF]

, 2007
Ketevan Pachkoria, M. Isabel Lucena, Francisco Ruiz‐Cabello, Esperanza Crespo, M.R. Cabello, Raúl J. Andrade, on behalf of the Spanish Group for the Study of Drug‐Induced Liver Disease (Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos (GEHAM)   +6 more
openalex   +1 more source

CYP2C9*1 Allele [PDF]

, 2020
openaire   +1 more source

Association Between <i>CYP2C9</i> and <i>CYP2C19</i> Genetic Polymorphisms and Antiseizure Medication-Induced Adverse Reactions Among Peruvian Patients with Epilepsy. [PDF]

Pharmaceuticals (Basel)
Alvarado AT, Ignacio-Cconchoy FL, Espinoza-Retuerto JC, Contreras-Macazana RM, Quiñones LA, García JA, Bendezú MR, Chávez H, Surco-Laos F, Laos-Anchante D, Cuba-Garcia PA, Melgar-Merino EJ, Pari-Olarte B, Bonifaz-Hernández M, Almeida-Galindo JS, Kong-Chirinos J, Pariona-Llanos R, Aguilar-Ramírez P, Varela NM.   +18 more
europepmc   +1 more source

CYP2C9*11 Allele [PDF]

, 2020
openaire   +1 more source